Welcome to our dedicated page for Lichen International SEC filings (Ticker: LICN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lichen International Limited filings document a China-based financial and taxation services issuer reporting as a foreign private issuer. Its Form 6-K reports include interim management discussion and analysis, unaudited consolidated financial statements, Inline XBRL exhibits, and current reports on corporate and capital-structure events.
The filing record covers shareholder meeting results, an increase in authorized share capital, a 2025 equity incentive plan, private placements of Class A ordinary shares, and a debt settlement involving the issuance of Class B ordinary shares. These disclosures also describe the company’s dual-class ordinary share structure, registration-statement references, governance approvals, and material agreements.
Lichen International Limited, a Cayman Islands holding company listed on Nasdaq, filed its Form 20-F for the year ended December 31, 2025. Operations are conducted through PRC subsidiaries, mainly Lichen Zixun and Bondly Xiamen, with revenues and costs largely in Renminbi.
The company reports 16,216,825 Class A ordinary shares and 110,000 Class B ordinary shares outstanding as of December 31, 2025, against authorized capital of 20 billion Class A and 5 billion Class B shares. It emphasizes that cash upstreaming depends on PRC subsidiaries’ after-tax profits and Chinese foreign-exchange rules.
The filing details PRC regulatory, foreign-exchange and legal-system risks, including potential limits on cross-border cash transfers, evolving CSRC filing regimes for offshore offerings, cybersecurity and data-review rules, and possible U.S. trading bans under the Holding Foreign Companies Accountable Act if PCAOB access is curtailed. The company does not expect to pay cash dividends in the foreseeable future.
Lichen International Limited reports that shareholders approved all six proposals at an extraordinary general meeting held on December 30, 2025. Holders representing 15,970,739 voting power, or 92.23% of eligible votes as of November 21, 2025, were present in person or by proxy. Shareholders approved a major increase in authorised share capital from US$1,000,000 divided into 100,000,000 Series A and 25,000,000 Series B ordinary shares to US$200,000,000 divided into 20,000,000,000 Series A and 5,000,000,000 Series B ordinary shares. They also approved a future share consolidation at a ratio between one-for-20 and one-for-200, with the exact ratio and effective date to be set by the board within eighteen months and fractional shares rounded up. The meeting adopted extensive amendments to the memorandum and articles of association, including making annual general meetings optional, updating quorum rules tied to listed status, and replacing the governing documents with amended and restated versions.
Lichen International Limited has filed a Form F-3 shelf registration to offer up to $500,000,000 of Class A ordinary shares, share purchase contracts and units, warrants, debt securities, rights and units in one or more future offerings. The company’s Class A ordinary shares trade on Nasdaq under the symbol LICN, with a public float of 16,215,274 Class A shares held by non‑affiliates as of this prospectus.
Lichen is a Cayman Islands holding company whose operations are conducted through PRC subsidiaries providing financial and taxation solutions, education support, and software services, without a VIE structure. The filing highlights significant PRC legal, regulatory, cash‑transfer and HFCAA-related risks that could affect the value or tradability of its securities. Recent developments include a strategic shift toward IPO advisory and external equity investments, a $18,600,000 private placement of 15,500,000 Class A shares at $1.20 per share, and adoption of a 2025 equity incentive plan for up to 2,500,000 Class A shares.
Lichen International Limited filed a Form S-8 to register 2,500,000 Class A ordinary shares, par value US$0.008 per share, for issuance under its 2025 Equity Incentive Plan.
The registration also includes, pursuant to Rule 416(a), an indeterminate number of additional shares to prevent dilution from share splits, share dividends or similar transactions. The filing incorporates by reference the company’s future Exchange Act reports and lists standard indemnification provisions for directors and officers under Cayman Islands law.
Lichen International Limited reported that its Board of Directors approved and adopted a new 2025 Equity Incentive Plan, effective October 30, 2025. The plan is included as Exhibit 99.1 to the company’s Form 6-K.
The filing is an administrative update that adds the full text of the equity plan for reference. The report was signed by Chief Executive Officer Ya Li on November 7, 2025.
Lichen International Limited completed a private placement of equity to raise new cash. On September 15, 2025, the company agreed to sell 15,500,000 Class A ordinary shares at $1.20 per share, for a total purchase price of $18,600,000, payable in cash.
The company received the full purchase price and issued the shares on September 19, 2025. The transaction was conducted as a private offering exempt from U.S. registration under Section 4(a)(2), Regulation D and/or Regulation S, and the related securities purchase agreement form was filed as an exhibit.
Lichen International Ltd settled accrued salary owed to its Chief Executive Officer, Ya Li, by issuing equity instead of paying cash. As of August 27, 2025, the Company owed Mr. Li RMB 2,129,544 (approximately $297,000) in unpaid salary for the period from January 2025 to June 2025. To extinguish this debt, the Company and Mr. Li entered into a debt settlement and mutual release agreement under which the Company issued 65,000 Class B ordinary shares, valued at $4.57 per share, which was approximately 102% of the average closing bid price of the Company’s Class A ordinary shares over the five trading days before the agreement date. The shares were issued on August 27, 2025 under exemptions from registration provided by Section 4(a)(2) of the Securities Act of 1933 and Regulation S.